共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | PLENDIL |
| 申请号 | 019834 | 产品号 | 001 |
| 活性成分 | FELODIPINE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, EXTENDED RELEASE;ORAL | 规格 | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 1991/07/25 | 申请机构 | ASTRAZENECA PHARMACEUTICALS LP
|
| 2 | 药品名称 | PLENDIL |
| 申请号 | 019834 | 产品号 | 002 |
| 活性成分 | FELODIPINE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, EXTENDED RELEASE;ORAL | 规格 | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 1991/07/25 | 申请机构 | ASTRAZENECA PHARMACEUTICALS LP
|
| 3 | 药品名称 | PLENDIL |
| 申请号 | 019834 | 产品号 | 004 |
| 活性成分 | FELODIPINE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, EXTENDED RELEASE;ORAL | 规格 | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 1994/09/22 | 申请机构 | ASTRAZENECA PHARMACEUTICALS LP
|